The SmallCapRelations Newsletter Where Promising Small-cap Market Plays Meet Forward-thinking Investors

The SmallCapRelations Newsletter Newsletter Archives

SmallCapRelationsSpotlight Company

Telomir Pharmaceuticals Inc. (NASDAQ: TELO)

Investment Considerations Telomir Pharmaceuticals is pioneering the development of Telomir-1, a novel small molecule with the potential to address the root causes of aging and age-related conditions by lengthening telomeres, positioning the company at the forefront of the emerging longevity market. The company’s dual focus on human and veterinary applications for Telomir-1 provides a diversified … Continue reading “Telomir Pharmaceuticals Inc. (NASDAQ: TELO)”

View Profile

Telomir Pharmaceuticals Inc.

Latest Press Releases

Filter Releases
Filters
Sector



Symbol Release Time Source
{{ release.qmtopics.qmsymbol[0].symbol }} {{ release.headline }} {{ release.datetime | amDateFormat:'hh:mm A'}} {{ release.source }}
IBN (InvestorBrandNetwork)

SmallCapRelations is part of the IBN (InvestorBrandNetwork).

SmallCapRelations (SCR) exists to enhance the communication between public entities and stakeholders through accurate, timely and informative messaging solutions. We also specialize in the unique communication needs of private companies planning to go public. With a substantial staff of corporate communication professionals, SCR builds a framework that rapidly conveys your brand's messaging to potential shareholders, clients, analysts, media and the general public.

Other brands within the network include:
CannabisNewsWire (CNW)
CryptoCurrencyWire (CCW)
MissionIR (MIR)
NetworkNewsWire (NNW)
QualityStocks (QS)
QualityStocksTwits
StocksToBuyNow (STBN)
SeriousTraders
Tip.us
TraderPower (TP)
Interested in a live, online demonstration?

Schedule a LIVE Demo